Peristaltic pumps in the pharmaceutical sector: selection criteria, technologies, and Engmotion’s experience
In recent years, peristaltic pumps have taken on an increasingly central role in pharmaceutical, biotech, and diagnostic processes. This growing relevance is not driven by market trends alone, but by the intrinsic ability of this technology to meet ever more stringent requirements in terms of precision, repeatability, process cleanliness, regulatory compliance, and operational flexibility.
At the same time, the increasing complexity of formulations and the reduction of batch sizes have led pharmaceutical companies to demand custom-engineered solutions, often well beyond standard catalogue products. It is within this context that Engmotion d.o.o. has, over the last two years, made a focused investment in developing advanced know-how in high-precision peristaltic pump technology, working closely with leading pharmaceutical companies to design, optimize, and validate tailored solutions.
Why peristaltic pumps are becoming central in the pharmaceutical industry
Are you interested in these solutions? Do not hesitate to contact us at sales@engmotion.com
Over the past decade, the pharmaceutical industry has undergone profound transformation, driven by regulatory evolution, technological innovation, and changing production models. In this environment, peristaltic pumps have progressively shifted from being simple utility components to becoming critical process elements, directly impacting product quality, compliance, and manufacturing flexibility.
This shift is the result of a clear convergence of multiple trends.
Regulatory evolution: EU GMP Annex 1 and Contamination Control Strategy
The revision of EU GMP Annex 1, which came into force in 2022, introduced a significant change in how aseptic and sterile manufacturing processes are designed, assessed, and maintained. The concept of a Contamination Control Strategy (CCS) requires a holistic view of the entire process, from raw material handling to final filling, with heightened attention to every potential source of contamination.
In this regulatory context, technologies that reduce the number of product-contact surfaces, simplify cleaning, and make risks more transparent and controllable have gained substantial importance. Peristaltic pumps, by fully isolating the fluid within the tubing, directly support these requirements and facilitate the development of robust and defensible CCS frameworks during regulatory inspections.
Single-use technologies, small batches, and manufacturing flexibility
Alongside regulatory changes, pharmaceutical manufacturing models are evolving. Personalized therapies, biologics, clinical trial materials, and advanced diagnostics are driving the shift toward smaller batch sizes, frequent product changeovers, and multipurpose production lines.
Single-use technologies represent a practical response to these needs, as they significantly reduce downtime, cleaning validation efforts, and the risk of cross-contamination. Peristaltic pumps naturally align with this paradigm: product changeover can be achieved by simply replacing the tubing or fluid set, without invasive mechanical interventions.
Quality Risk Management and ICH Q9(R1)
The revision of ICH Q9(R1) has reinforced the role of Quality Risk Management (QRM) as a living, continuous process rather than a one-time design exercise. Pharmaceutical manufacturers are now expected to demonstrate that technical choices are consistent with the level of process risk and that these choices are periodically reviewed throughout the product lifecycle.
Within this framework, well-characterized peristaltic pumps with predictable and controllable behavior simplify risk management activities. The ability to correlate mechanical and software parameters with dosing performance improves process transparency and strengthens regulatory defensibility.
Digitalization, Annex 11, and data integrity
Another key driver is the increasing digitalization of pharmaceutical manufacturing. EU GMP Annex 11 (Computerised Systems) explicitly extends GMP expectations to software, recipes, parameters, and process data. As a result, dosing pumps are no longer considered purely mechanical devices, but integral parts of computerised systems that must ensure data integrity, traceability, and reproducibility.
Modern peristaltic pumps, when integrated with advanced control software, calibration strategies, and in-line gravimetric verification, are particularly well suited to this environment. They transform dosing from a mechanical action into a controlled, documented, and auditable process function.
Biologics and complex fluids
The growing use of biologics and sensitive formulations has further increased the relevance of peristaltic pumps. These products often require gentle handling, with carefully controlled motion profiles to minimize shear stress and preserve the integrity of the active substance.
A properly engineered peristaltic pump allows fine tuning of speed, acceleration, deceleration, and suction strategies, adapting to fluids with widely varying viscosities and rheological behaviors.
From standard component to engineered system
The combined effect of stricter regulations, evolving production models, and increasing product complexity has transformed the peristaltic pump into an engineered system, requiring integrated mechanical, process, and software expertise.
It is precisely within this context that Engmotion d.o.o.’s work over the past two years should be positioned. Through close collaboration with leading pharmaceutical companies, Engmotion has developed and refined custom high-precision peristaltic pump solutions, building practical, application-driven know-how that today represents a core element of the company’s technical competence.
The operating principle: apparent simplicity, real complexity
The operating principle of a peristaltic pump is deceptively simple: a set of rollers compresses a flexible tube in a controlled manner, generating fluid movement inside the tubing. The fluid never comes into contact with mechanical components, only with the tube itself.
This characteristic makes peristaltic technology particularly attractive for pharmaceutical applications, where contamination control, cleaning efficiency, and product integrity are critical. However, achieving high precision and repeatability, especially in micro-dosing applications, requires careful engineering of the pump head geometry, roller configuration, materials, and control strategy.
Types of peristaltic pumps: not all designs are equal
In common language, peristaltic pumps are often considered standardized components. In practice, significant design differences directly affect performance:
Number of rollers: higher roller counts reduce pulsation and improve flow stability.
Roller geometry: symmetric versus asymmetric rollers influence tubing compression and volumetric linearity.
Single-channel vs. dual-channel configurations: dual-channel designs can enhance dosing stability and enable advanced compensation strategies.
Pump head opening mechanism: one-hand, hinged-lid designs improve ergonomics and reduce operator error during tubing changes.
In pharmaceutical applications, advanced solutions typically feature multi-roller, dual-channel architectures with optimized kinematics, specifically engineered to minimize variability and enhance repeatability.
Materials: a frequently underestimated factor
Material selection plays a critical role in peristaltic pump performance and suitability for pharmaceutical environments:
Structural materials: pharmaceutical-grade stainless steels, anodized aluminum alloys, and technical polymers provide durability and environmental compatibility.
Rollers and moving components: bearing quality, mechanical tolerances, and surface treatments directly influence long-term repeatability.
Tubing materials: platinum-cured silicone and equivalent GMP-compliant materials are essential, but their interaction with pump geometry must be carefully evaluated.
A high-precision peristaltic pump cannot be designed without a coherent approach to materials, geometry, and mechanical interfaces.
Precision and repeatability: beyond catalogue values
In pharmaceutical applications, precision is never an isolated specification, but the outcome of a complete system.
Speed, acceleration, deceleration, fluid viscosity, tubing diameter, and calibration strategy all contribute to final dosing performance. For this reason, pharmaceutical-grade peristaltic pumps require:
application-specific performance characterization across defined volume ranges;
robust calibration strategies, both off-line and increasingly in-line;
advanced software control, capable of adapting parameters to process conditions.
Without this system-level approach, even high-quality mechanical components may fail to meet critical application requirements.
Engmotion’s experience: from component supply to applied know-how
Over the past two years, Engmotion d.o.o. has pursued a targeted path toward the development of custom high-precision peristaltic pumps for pharmaceutical applications. This effort has extended far beyond mechanical design and has included:
advanced pump head engineering;
optimization of roller kinematics;
integration with dosing control software;
performance characterization and validation on real processes.
Collaboration with leading pharmaceutical companies has enabled Engmotion to translate process requirements into concrete, validated solutions, resulting in a solid, application-driven body of know-how that today forms a key part of the company’s technical identity.
Standard versus custom solutions: a strategic decision
Not every application requires a pharmaceutical-grade, ultra-high-precision peristaltic pump. In many laboratory and pre-production contexts, simpler standardized solutions can be perfectly adequate and economically justified.
The critical factor is informed decision-making: understanding when a standard solution is sufficient and when process risk, regulatory exposure, or performance requirements justify a custom-engineered approach.
Engmotion operates precisely at this interface, offering both reliable standard solutions for less critical applications and highly engineered peristaltic pumps for environments where precision, repeatability, and process control are non-negotiable.
From custom pharma solutions to compact lab automation: the role of E-Lab Filler
The know-how developed by Engmotion in the field of high-precision peristaltic pumps for pharmaceutical applications is not confined to large or fully customized systems. The same engineering principles—control of the fluid path, careful selection of pump architecture, and integration between mechanics and software—are also reflected in Engmotion’s compact filling solutions, such as the E-Lab Filler platform.
Do you want to discover more about the E-Lab Filler? Click here - E-Lab Filler Contact
E-Lab Filler is designed as a flexible laboratory and small-batch filling system and can be equipped with different peristaltic pump options, selected according to the required level of precision, process criticality, and application context. Depending on the configuration, the system may integrate:
standard single-channel peristaltic pumps for general laboratory and development activities;
higher-precision peristaltic pump configurations for applications requiring improved repeatability and tighter control;
advanced pump options combined with gravimetric control and recipe-based software for regulated or pre-production environments.
This modular approach allows users to adopt a solution that is aligned with their current needs while preserving a clear upgrade path toward more advanced, pharma-oriented configurations. In this sense, E-Lab Filler acts as a practical bridge between laboratory-scale operations and more demanding pharmaceutical processes, leveraging the same core expertise that Engmotion applies in fully custom pump developments.
Conclusion
Today, peristaltic pumps represent far more than simple fluid transfer devices. In the pharmaceutical industry, they have become key enablers of process quality, regulatory compliance, and manufacturing flexibility.
The experience gained by Engmotion d.o.o. in recent years demonstrates how targeted investment in engineering, validation, and close collaboration with pharmaceutical partners is essential to developing peristaltic pump solutions capable of meeting the evolving challenges of modern pharma manufacturing.